XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.21.1

DERIVATIVE FINANCIAL INSTRUMENTS (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
DERIVATIVE FINANCIAL INSTRUMENTS |
Schedule of fair value of the Company's derivative financial instruments as well as classification on the condensed consolidated balance sheets | The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020 (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Liability Derivatives | ​
​ | ​ | ​ | ​ | Fair value as of: | ​
Derivatives designated as | ​ | Balance Sheet | ​ | March 31, | ​ | December 31, | ​
hedging instruments |  | Location |  | 2021 |  | 2020 |
Interest rate products | ​ | Accrued liabilities | ​ | $ | 677 | ​ | $ | — | ​
Interest rate products | ​ | Other long-term liabilities | ​ | ​ | 284 | ​ | ​ | 1,889 | ​
Foreign currency contracts | ​ | Accrued liabilities | ​ | ​ | 14 | ​ | ​ | — | ​
​ | ​ | ​ | ​ | $ | 975 | ​ | $ | 1,889 | ​
​
Schedule of effect of cash flow hedge accounting on other comprehensive income (loss) (OCI) | The tables below present the effect of cash flow hedge accounting on other comprehensive income (loss) (“OCI”) for the three months ended March 31, 2021 and 2020 (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount of pre-tax gain (loss) recognized | ​
​ | ​ | in OCI on derivatives | ​
Derivatives in cash flow hedging relationships | ​ | Three months ended March 31, | ​
​ |  | 2021 |  | 2020 |
Interest rate products | ​ | $ | 704 | ​ | $ | (1,463) | ​
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount of pre-tax (loss) gain reclassified | ​
​ | ​ | from accumulated OCI into income | ​
Location of (loss) gain reclassified | ​ | Three months ended March 31, | ​
from accumulated OCI into income |  | 2021 |  | 2020 | ​
​ |  | ​ | ​ |  | ​ | ​ |
Interest expense | ​ | $ | (225) | ​ | $ | (31) | ​
Schedule of effect of the Company's derivative financial instruments on the condensed consolidated statements of income and comprehensive income | The table below presents the effect of the Company’s derivative financial instruments on the condensed consolidated statements of income and comprehensive income for the three months ended March 31, 2021 and 2020 (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Total amounts of income and expense | ​
​ | ​ | ​ | ​ | line items presented that reflect the | ​
​ | ​ | ​ | ​ | effects of cash flow hedges recorded | ​
​ | ​ | ​ | ​ | Three months ended March 31, | ​
Derivatives designated as hedging instruments |  | Income Statement Location |  | 2021 |  | 2020 |
Interest rate products |  | Interest Expense | ​ | $ | 861 | ​ | $ | 1,054 | ​
Schedule of fair value provides the location that derivative assets and liabilities | The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented in the condensed consolidated balance sheets (in thousands). ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Gross amounts | ​ | Net amounts of liabilities | ​ | Gross amounts not offset in the consolidated
As of | ​ | Gross amounts | ​ | offset in the | ​ | presented in the | ​ | balance sheets
March 31, | ​ | of recognized | ​ | consolidated | ​ | consolidated | ​ | Financial | ​ | Cash collateral | ​ | ​ | ​
2021 |  | liabilities |  | balance sheets |  | balance sheets |  | instruments |  | received |  | Net amount
Derivatives | ​ | $ | 983 | ​ | $ | 8 | ​ | $ | 975 | ​ | $ | — | ​ | $ | — | ​ | $ | 975
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Gross amounts | ​ | Net amounts of liabilities | ​ | Gross amounts not offset in the consolidated
As of | ​ | Gross amounts | ​ | offset in the | ​ | presented in the | ​ | balance sheets
December 31, | ​ | of recognized | ​ | consolidated | ​ | consolidated | ​ | Financial | ​ | Cash collateral | ​ | ​ | ​
2020 |  | liabilities |  | balance sheets |  | balance sheets |  | instruments |  | received |  | Net amount
Derivatives | ​ | $ | 1,889 | ​ | $ | — | ​ | $ | 1,889 | ​ | $ | — | ​ | $ | — | ​ | $ | 1,889

X
- Definition The tabular disclosure of gross presentation, the effects of offsetting, and a net presentation of financial instruments. + References No definition available. + Details
Name: | amot_ScheduleOfGrossOffsetAndNotOffsetAndFinancialInstrumentsNetTableTextBlock
Namespace Prefix: | amot_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4E -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration